Puerta Angel, Martin-Alvarez Pedro J, Ongay Sara, Diez-Masa Jose C, de Frutos Mercedes
Institute of Organic Chemistry (IQOG-CSIC), Madrid, Spain.
Methods Mol Biol. 2013;919:215-30. doi: 10.1007/978-1-62703-029-8_20.
Variations in the amino acid sequence, glycosylation, and/or other posttranslational modifications in glycoproteins give rise to different molecules of the glycoprotein called forms. Qualitative and/or quantitative alterations in these forms are related to pathophysiological situations in the individuals. In this study, a methodology to analyze these differences in forms of the alpha 1-acid glycoprotein (AGP) between healthy individuals and patients with two different vascular diseases is detailed. The whole methodology includes a sample preparation method based on immunochromatography, a capillary electrophoresis method for separation of AGP peaks (isoforms), and statistical methods (Linear Discriminant Analysis) for sample classification. As a result, it is shown that the methodology proposed allows studying the role of AGP isoforms as potential vascular disease biomarkers.
糖蛋白中氨基酸序列、糖基化和/或其他翻译后修饰的变化会产生被称为糖蛋白形式的不同分子。这些形式的定性和/或定量改变与个体的病理生理状况相关。在本研究中,详细阐述了一种分析健康个体与患有两种不同血管疾病的患者之间α1-酸性糖蛋白(AGP)形式差异的方法。整个方法包括基于免疫色谱的样品制备方法、用于分离AGP峰(异构体)的毛细管电泳方法以及用于样品分类的统计方法(线性判别分析)。结果表明,所提出的方法能够研究AGP异构体作为潜在血管疾病生物标志物的作用。